Linn Stefan C 4
4 · Oxford Immunotec Global PLC · Filed Apr 3, 2019
Insider Transaction Report
Form 4
Linn Stefan C
Chief Operating Officer
Transactions
- Award
Ordinary Shares
2019-04-01+20,901→ 59,066 total - Award
Share Option (Right to Buy)
2019-04-01+44,853→ 44,853 totalExercise: $16.42Exp: 2029-04-01→ Ordinary Shares (44,853 underlying)
Footnotes (2)
- [F1]Options granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2020 through January 1, 2023.